Uribe M, Alba A, Hunter B, Valverde C, Godoy J, Ferrario M, Buckel E, Cavallieri S, Rebolledo R, Herzog C, Calabrán L, Flores L, Soto P
Centro de Trasplante Clinica Las Condes and the Hospital Luis Calvo, Santiago, Chile.
Transplant Proc. 2010 Jan-Feb;42(1):293-5. doi: 10.1016/j.transproceed.2009.12.050.
Acute liver failure (ALF) in children is a life-threatening condition, associated with high mortality, and in almost one third of the cases, with no other therapeutic option than orthotopic liver transplant (OLT). The aim of this study was to present our experience with OLT for ALF in pediatric patients in Chile. Patients fulfilling the criteria for ALF who were transplanted in our centers were prospectively included in an excel Microsoft database. We analyzed demographics, etiology, surgical techniques, complications, and long-term results.
Between 1994 and 2009, we transplanted 52 pediatric patients with ALF. The most frequent known etiology was acute hepatitis A in 9 cases (18%), but in 26 cases (50%) it was impossible to determine the etiology. Thirty- one patients were males (63%). The overall mean age was 7.5 years and the mean weight, 28.1 kg. Thirty-five (67%) received a cadaveric graft. Among them in 18 cases (34%) the liver had to be reduced but 17 (33%) received whole livers. There were 17 (33%) recipients of living-related livers. Twenty-two patients needed reoperation, including 13 due to surgical complications (59%) and 9 (41%) as planned interventions. Ten patients were retransplanted.
Actuarial survival of patients at 1 year was 80% and at 5 and 10 years, 72%. Graft survival at 1 year was 79%, at 5 years 69%, and at 10 years 50%.
We have reported a series of pediatric liver transplant patients due to ALF whose results were comparable to other reported series. Living donor transplantation for ALF should be considered and offers a low morbidity rate without mortality.
儿童急性肝衰竭(ALF)是一种危及生命的疾病,死亡率很高,几乎三分之一的病例除原位肝移植(OLT)外没有其他治疗选择。本研究的目的是介绍我们在智利为小儿ALF患者进行OLT的经验。符合ALF标准并在我们中心接受移植的患者被前瞻性纳入微软Excel数据库。我们分析了人口统计学、病因、手术技术、并发症和长期结果。
1994年至2009年期间,我们为52例小儿ALF患者进行了移植。最常见的已知病因是9例(18%)急性甲型肝炎,但26例(50%)无法确定病因。31例患者为男性(63%)。总体平均年龄为7.5岁,平均体重为28.1千克。35例(67%)接受了尸体供肝移植。其中18例(34%)肝脏需要缩小,但17例(33%)接受了全肝。17例(33%)接受了亲属活体供肝移植。22例患者需要再次手术,其中13例(59%)是由于手术并发症,9例(41%)是作为计划性干预措施。10例患者接受了再次移植。
患者1年实际生存率为80%,5年和10年为72%。移植物1年生存率为79%,5年为69%,10年为50%。
我们报告了一系列因ALF接受小儿肝移植的患者,其结果与其他报告的系列相当。对于ALF,应考虑活体供体移植,其发病率低且无死亡率。